Idamycin PFS® (idarubicin hydrochloride injection)

1 mg/mL

5 mg/5 mL

CYTOSAFE® Single-use Vial

Unit of Sale NDC: 00013-2576-91

Depleted
To set product alerts you must or register

Cap color: Natural

Product insert Safety data sheet
Wholesalers
Cardinal 3287265
Cencora 10012018
McKesson 1174408
Morris & Dickson 423251
Ordering information
Unit of Sale size 1 Vial
Case size 60 x 1
Unit of Sale weight 0.04
Unit of Sale per shipper 60
Shipper outer dimensions 10
Shipper weight 4
Allergy information
Latex information
Preservative free
Gluten free
Availability specifics
Additional information View

If Latex Information is present above, then natural rubber latex has not been used in the manufacturing of this device or drug container closure system.

If Preservative Free is present above, then this product does not contain ingredients identified as a preservative, as defined by the USP.

Cap color: Natural

Unit of Sale NDC:00013-2576-91

Idamycin PFS® (idarubicin hydrochloride injection)

Unit of Sale NDC:
00013-2576-91

Unit of Use NDC:00013-2576-91

Idamycin PFS® (idarubicin hydrochloride injection)

Unit of Use NDC:
00013-2576-91

Additional family SKUs (5)

Available
To set product alerts you must or register

Idamycin PFS® (idarubicin hydrochloride injection)

5mg/5ml

Onco-Tain™ Single Dose Glass Fliptop Vial

UoS NDC: 00013-2576-05
Available
To set product alerts you must or register

Idamycin PFS® (idarubicin hydrochloride injection)

10 mg/10 mL

Onco-Tain™ Single Dose Glass Fliptop Vial

UoS NDC: 00013-2586-10
Available
To set product alerts you must or register

Idamycin PFS® (idarubicin hydrochloride injection)

20 mg/20 mL

Onco-Tain™ Single Dose Glass Fliptop Vial

UoS NDC: 00013-2596-20
Depleted
To set product alerts you must or register

Idamycin PFS® (idarubicin hydrochloride injection)

20 mg/20 mL

CYTOSAFE® Single-use Vial

UoS NDC: 00013-2596-91
Depleted
To set product alerts you must or register

Idamycin PFS® (idarubicin hydrochloride injection)

10 mg/10 mL

CYTOSAFE® Single-use Vial

UoS NDC: 00013-2586-91

Related news

Product Updates

Product NDC and Vial Presentation Changes for Camptosar® (Irinotecan Hydrochloride Injection, USP) 40 mg/2 mL (20 mg/mL) Single Dose Vial and Camptosar® (Irinotecan Hydrochloride Injection, USP) 100 mg/5 mL (20 mg/mL) Single Dose Vial

Product Updates

Product NDC and Pack Size Change: Marcaine® 0.5% (bupivacaine hydrochloride injection, USP) 250 mg/50 mL (5 mg/mL) Multiple Dose Glass Fliptop Vial

Product Updates

Product NDC and Vial Presentation Change DOXOrubicin Hydrochloride Injection, USP 50 mg/25 mL (2 mg/mL) Single Dose Vial

Product Updates

Product NDC and Pack Size Changes for Lidocaine HCl 1% 200 mg/20 mL (10 mg/mL) and Epinephrine 1:100,000 Injection, USP Multiple Dose Glass Fliptop Vial

Product Updates

Product NDC and Vial Presentation Change for DOXOrubicin Hydrochloride Injection, USP, Multiple Presentations

Product Updates

Product NDC Change for Idamycin PFS® (idarubicin hydrochloride injection) 5 mg/5 mL (1 mg/mL) Single Dose Vial

Product Updates

NDC and Pack Size Change for Sterile Empty Vial 10 mL Glass Bottle

Product Updates

Product NDC and Vial Presentation Change for DOXOrubicin Hydrochloride Injection, USP 200 mg/100 mL (2 mg/mL) Multiple Dose Vial

Product Updates

Product NDC and Vial Presentation Change for Camptosar® (Irinotecan Hydrochloride Injection, USP) 300 mg/15 mL (20 mg/mL) Single Dose Vial

Product Updates

NDC and Formulation Change for Levofloxacin in 5% Dextrose Injection Flexible Container Presentations

Product Updates

NDC Change for Idamycin PFS® (idarubicin hydrochloride injection), 10 mg/10 mL (1 mg/mL) Single Dose Vial

Product Updates

NDC Change for Idamycin PFS® (idarubicin hydrochloride injection), 20 mg/20 mL

Recalls Withdrawals or Important Safety Information

Urgent Recall: Bleomycin for Injection, USP, 15 Units Single-Dose ONCO-TAIN™ Glass Fliptop Vial

Product Updates

Pfizer Hospital NDC and Packaging Change: Precedex

Product Updates

Pfizer Hospital NDC and Labeling Change: Morphine

Product Updates

NDC Updates